{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:48:12Z","timestamp":1762980492841,"version":"3.40.5"},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.hlc.2017.11.013","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T13:54:50Z","timestamp":1513000490000},"page":"e70-e72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recurrent Bioprosthetic Valve Thrombosis \u2014 Should Long-Term Anticoagulation Be Considered?"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5866-0034","authenticated-orcid":false,"given":"Matthew S.","family":"Yong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2017.11.013_bib0005","first-page":"1591","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"374","author":"Makkar","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2017.11.013_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jcin.2016.11.027","article-title":"Outcomes of warfarin therapy for bioprosthetic valve thrombosis of surgically implanted valves: a prospective study","volume":"10","author":"Egbe","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2017.11.013_bib0015","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.jacc.2016.09.958","article-title":"Prosthetic heart valve thrombosis","volume":"68","author":"Dangas","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2017.11.013_bib0020","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jacc.2015.09.022","article-title":"Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors","volume":"66","author":"Egbe","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395061731507X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395061731507X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T05:36:47Z","timestamp":1535175407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144395061731507X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S144395061731507X"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2017.11.013","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent Bioprosthetic Valve Thrombosis \u2014 Should Long-Term Anticoagulation Be Considered?","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2017.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}